Already a Bloomberg.com user?
Sign in with the same account.
APEX BIOTECH said unconsolidated sales in May rose 12.86% to NT$184,333,000 from NT$163,322,000, according to a statement filed to the Taiwan Stock Exchange.
(Figures are in thousands of New Taiwan dollars)
5/2012 5/2011 Sales 184,333 163,322 YOY% 12.86%
-----------------Year-to-date----------------- Sales 922,717 677,332 YOY% 36.23% =================================================================